Abstract
This paper looks at the use of cross-sectional data in pharmaceutical health outcomes
research. NATSEM attempted cutting edge research on health outcomes using the
NATSEM-Medicines Australia MedSim basefile. The results from this analysis are
not robust and are generally quite problematic. The key limitation is that in using
cross-sectional data it was not able to show that the groups being compared were the
same except for the use of medications. For future work, it may be preferable to
explore health outcomes using longitudinal patient level data (for the Australian
population).
research. NATSEM attempted cutting edge research on health outcomes using the
NATSEM-Medicines Australia MedSim basefile. The results from this analysis are
not robust and are generally quite problematic. The key limitation is that in using
cross-sectional data it was not able to show that the groups being compared were the
same except for the use of medications. For future work, it may be preferable to
explore health outcomes using longitudinal patient level data (for the Australian
population).
| Original language | English |
|---|---|
| Place of Publication | Canberra |
| Publisher | NATSEM |
| Pages | 1-42 |
| Number of pages | 42 |
| Volume | 31 |
| ISBN (Print) | 1740882512 |
| Publication status | Published - 2006 |